T2 Biosystems (TTOO) Competitors $0.13 +0.01 (+4.58%) As of 03/26/2025 03:52 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TTOO vs. NURO, WOK, IINN, LUCY, PAVM, MHUA, POAI, STRR, BLAC, and AEMDShould you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include NeuroMetrix (NURO), WORK Medical Technology Group LTD Ordinary Shares (WOK), Inspira Technologies Oxy B.H.N. (IINN), Innovative Eyewear (LUCY), PAVmed (PAVM), Meihua International Medical Technologies (MHUA), Predictive Oncology (POAI), Star Equity (STRR), Bellevue Life Sciences Acquisition (BLAC), and Aethlon Medical (AEMD). These companies are all part of the "medical equipment" industry. T2 Biosystems vs. NeuroMetrix WORK Medical Technology Group LTD Ordinary Shares Inspira Technologies Oxy B.H.N. Innovative Eyewear PAVmed Meihua International Medical Technologies Predictive Oncology Star Equity Bellevue Life Sciences Acquisition Aethlon Medical T2 Biosystems (NASDAQ:TTOO) and NeuroMetrix (NASDAQ:NURO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk. Does the MarketBeat Community believe in TTOO or NURO? T2 Biosystems received 122 more outperform votes than NeuroMetrix when rated by MarketBeat users. Likewise, 62.85% of users gave T2 Biosystems an outperform vote while only 57.03% of users gave NeuroMetrix an outperform vote. CompanyUnderperformOutperformT2 BiosystemsOutperform Votes40662.85% Underperform Votes24037.15% NeuroMetrixOutperform Votes28457.03% Underperform Votes21442.97% Which has more volatility & risk, TTOO or NURO? T2 Biosystems has a beta of 0.34, suggesting that its share price is 66% less volatile than the S&P 500. Comparatively, NeuroMetrix has a beta of 2.15, suggesting that its share price is 115% more volatile than the S&P 500. Do analysts prefer TTOO or NURO? T2 Biosystems currently has a consensus target price of $5.00, suggesting a potential upside of 3,884.06%. Given T2 Biosystems' stronger consensus rating and higher probable upside, analysts plainly believe T2 Biosystems is more favorable than NeuroMetrix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score T2 Biosystems 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00NeuroMetrix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals believe in TTOO or NURO? 23.2% of T2 Biosystems shares are held by institutional investors. Comparatively, 19.4% of NeuroMetrix shares are held by institutional investors. 0.0% of T2 Biosystems shares are held by insiders. Comparatively, 7.3% of NeuroMetrix shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media favor TTOO or NURO? In the previous week, NeuroMetrix had 2 more articles in the media than T2 Biosystems. MarketBeat recorded 3 mentions for NeuroMetrix and 1 mentions for T2 Biosystems. NeuroMetrix's average media sentiment score of 0.93 beat T2 Biosystems' score of 0.00 indicating that NeuroMetrix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment T2 Biosystems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeuroMetrix 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, TTOO or NURO? NeuroMetrix has lower revenue, but higher earnings than T2 Biosystems. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioT2 Biosystems$7.68M0.34-$50.08MN/AN/ANeuroMetrix$3.77M2.44-$6.53M-$4.59-0.97 Is TTOO or NURO more profitable? NeuroMetrix has a net margin of -203.71% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat NeuroMetrix's return on equity.Company Net Margins Return on Equity Return on Assets T2 Biosystems-563.16% N/A -174.06% NeuroMetrix -203.71%-42.56%-39.26% SummaryNeuroMetrix beats T2 Biosystems on 8 of the 15 factors compared between the two stocks. Remove Ads Get T2 Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTOO vs. The Competition Export to ExcelMetricT2 BiosystemsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.64M$4.42B$5.63B$8.15BDividend YieldN/A32.62%4.55%4.02%P/E RatioN/A28.7924.4719.08Price / Sales0.3449.55384.5794.27Price / CashN/A51.0838.1634.64Price / Book-0.026.166.954.36Net Income-$50.08M$67.64M$3.20B$247.23M7 Day Performance15.14%-0.66%-2.42%-0.61%1 Month Performance-5.64%-2.43%2.18%-5.12%1 Year Performance-95.61%19.33%12.85%3.60% T2 Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTOOT2 BiosystemsN/A$0.13+4.6%$5.00+3,884.1%-95.6%$2.64M$7.68M0.00180Analyst ForecastNews CoverageNURONeuroMetrix0.9587 of 5 stars$4.43+1.3%N/A+10.4%$9.09M$3.77M-0.9620Upcoming EarningsShort Interest ↓WOKWORK Medical Technology Group LTD Ordinary SharesN/A$0.62-3.1%N/AN/A$9.05M$11.51M0.00226Positive NewsGap DownIINNInspira Technologies Oxy B.H.N.0.6687 of 5 stars$0.72-2.0%N/A-58.7%$9.02MN/A0.0020LUCYInnovative Eyewear0.9114 of 5 stars$3.69-1.1%$20.00+442.0%-51.1%$9.01M$1.56M-0.389Earnings ReportGap UpPAVMPAVmed4.394 of 5 stars$0.77+17.1%$19.00+2,358.0%-60.4%$8.56M$4.03M-0.1890Short Interest ↓News CoverageHigh Trading VolumeMHUAMeihua International Medical Technologies2.2167 of 5 stars$0.34+6.7%N/A-54.0%$8.43M$94.25M0.00620Short Interest ↓Positive NewsGap DownPOAIPredictive Oncology2.358 of 5 stars$1.16+3.6%$3.00+158.6%-40.5%$7.94M$1.48M-0.3830Short Interest ↓STRRStar Equity1.2558 of 5 stars$2.20+0.2%N/A-44.0%$7.06M$50.38M-0.85460Earnings ReportUpcoming EarningsAnalyst RevisionPositive NewsGap UpBLACBellevue Life Sciences AcquisitionN/A$1.44-2.4%N/A-85.0%$5.80MN/A0.00N/AGap UpHigh Trading VolumeAEMDAethlon Medical3.1392 of 5 stars$0.38+0.7%$7.00+1,760.7%-77.0%$5.44M$570,000.00-0.2410Short Interest ↓News Coverage Remove Ads Related Companies and Tools Related Companies NeuroMetrix Competitors WORK Medical Technology Group LTD Ordinary Shares Competitors Inspira Technologies Oxy B.H.N. Competitors Innovative Eyewear Competitors PAVmed Competitors Meihua International Medical Technologies Competitors Predictive Oncology Competitors Star Equity Competitors Bellevue Life Sciences Acquisition Competitors Aethlon Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TTOO) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TTOO Stock Free TTOO Stock Alerts